Bristol-Myers Squibb Europe — Property, plant and equipment increased by 1.5% to $7.66B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 6.2%, from $7.21B to $7.66B. Over 5 years (FY 2020 to FY 2025), Europe — Property, plant and equipment shows an upward trend with a 5.1% CAGR.
An increase suggests capital expansion or infrastructure investment in the region, while a decrease may indicate asset divestiture, depreciation, or a shift toward outsourcing production.
This metric represents the net book value of tangible assets, including manufacturing facilities, laboratories, and admi...
Peers in the pharmaceutical industry typically report regional property, plant, and equipment values to demonstrate their global manufacturing footprint and supply chain resilience.
bmy_segment_europe_property_plant_and_equipment| Q2 '21 | Q3 '21 | Q4 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.80B | $5.87B | $6.05B | $1.18B | $6.05B | $5.97B | $6.04B | $6.26B | $6.28B | $6.36B | $6.48B | $6.65B | $6.75B | $6.85B | $6.90B | $7.14B | $7.21B | $7.37B | $7.35B | $7.54B | $7.66B |
| QoQ Change | — | +1.3% | +3.1% | -80.6% | +414.2% | -1.3% | +1.1% | +3.6% | +0.4% | +1.2% | +2.0% | +2.5% | +1.6% | +1.4% | +0.8% | +3.4% | +1.1% | +2.2% | -0.3% | +2.6% | +1.5% |
| YoY Change | — | — | — | — | — | +3.0% | +2.8% | +3.4% | +3.8% | +6.4% | +7.4% | +6.3% | +7.5% | +7.7% | +6.5% | +7.4% | +6.9% | +7.7% | +6.5% | +5.7% | +6.2% |